Oct 05, 2021
Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc are now subsidiaries of Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) CHICAGO --(BUSINESS WIRE)--Oct. 5, 2021-- Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company leveraging its novel formulation technology platforms to develop
Aug 19, 2021
Patents and patent applications provide additional coverage for XeriSol™ and XeriJect™ technology platforms CHICAGO --(BUSINESS WIRE)--Aug. 19, 2021-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and